Abstract:OBJECTIVE:To investigate the clinical features and treatment of multifocal papillary thyroid carcinoma (PTC).METHODS:A retrospective survey was carried out in 648 patients with PTC who underwent surgery from January 1997 to December 2006. One hundred and sixty-eight cases of the patients presented with multiple tumor masses (> or = 2). The risk factors, including sex of the patients, age at diagnosis, family history of thyroid tumor, multiplicity and bilaterality of tumor, extra-thyroidal extension, lymph node involvement and other were analyzed between solitary PTC and multifocal PTC group.RESULTS:The mean age of the patients was 42 years (range, 14 - 78 years), included 49 male and 119 female. Tumor foci were found in both thyroid lobes in 117 cases (69.6%). Patients with multifocal PTC were characterized by a higher ratio of male (P = 0.004), family history of thyroid tumor (P = 0.031), neck lymph node metastasis (P = 0.008) and extra-thyroidal extension (P = 0.001). However, solitary PTC tended to be with a higher rate of benign goiters in pathologic examination. In multifocal PTC group, male, neck lymphadenectasis, > or = 3 tumor masses or bilaterality of tumor tended to presented with larger tumor, more neck lymph node metastasis and extra-thyroidal extension; And a less malignant tumor in the cases detected with benign goiters in histological examination. By the end of 2007, 164 cases (97.6%) completed follow-up with a mean period of 46.1 months (range, 2 - 127 months), 5 died in the meantime. One patient has been followed-up for 16 months for suspect of lung metastases by chest X-ray. Recurrence occurred in 8 patients and were re-resected, 2 in remnant thyroid and 6 in neck lymph nodes. The overall 1-, 2-, 5-, and 10-year survival rate was 98.2%, 97.4%, 96.5% and 96.5%, respectively. American Joint Committee on Cancer (AJCC) stage was associated with prognosis significantly (chi(2) = 168.832, P = 0.000).CONCLUSIONS:Multifocus is one of the clinical features of PTC and is more malignant than solitary PTC. Total thyroidectomy with central compartment neck dissection could be standard treatment. Lateral nodal dissection is not necessary except for the cases with lymph node metastasis. AJCC stage is still the best prognostic factor.

Retrospective analysis of diagnosis and surgical treatment for thyroid microcarcinoma

Thyroid microcarcimoma

Preoperative diagnosis and surgical treatments of thyroid microcarcinoma

Study on Ultrasound-guided Percutaneous Microwave Ablation and Surgical Resection for Papillary Thyroid Microcarcinoma

Differentiated Microcarcinoma of the Thyroid Gland in 45 Cases

Experience in 221 cases of surgical treatment of thyroid cancer

[Primary Squamous Cell Carcinoma of the Thyroid: Retrospective Analysis of 28 Cases].

[Type of Surgery for 147 Patients with Medullary Carcinoma of the Thyroid].

[Diagnosis and Treatment of Parathyroid Carcinoma: 9 Cases Report and Literature Review].

Clinicopathological Analysis of Thyroid Papillary Microcarcinoma

A Single-Center Analysis of the Treatment and Prognosis of Patients with Thymic Carcinoma

Multifocal Papillary Thyroid Carcinoma: Clinical Analysis of 168 Cases

Conformal thyroidectomy is a feasible option in papillary thyroid microcarcinoma: a retrospective cohort study with 10-year follow-up results

Clinicopathological and Prognostic Analysis of Follicular Thyroid Carcinoma in a Single Institute over a 15-Year Period

Clinical Pathology Analysis of Primary Squamous Cell Carcinoma of the Thyroid

Long-Term Survival After Surgical Treatment of Thymic Carcinoma: A Retrospective Analysis from the Chinese Alliance for Research of Thymoma Database

Clinical features and prognosis of patients with benign thyroid disease accompanied by an incidental papillary carcinoma.

Transition Analysis in the Clinicopathology and Prognosis of 2 682 Papillary Thyroid Carcinoma Cases over a 15-Year Period

[Thyroid-stimulating hormone pituitary adenomas: clinical characteristics, diagnosis and treatment]

Clinical analysis of 13 cases of primary squamous-cell thyroid carcinoma